Indo-US Science & Technology Forum
Indo-US Public- Private Networked Joint Centres To enable Indian and American scientists from academia and industry to carry out joint research activity by leveraging already existing infrastructure and funding available with the partners at both sides through a linkage established by a virtual networked centre. Public-Private Networked Centres enables to foster academia-industry partnership by promoting pre-commercial R & D activities having potential towards applied research and product development. These Centres are aimed to best capitalize on the scientific and technological innovation and entrepreneurship in translating ideas from bench to market place. Eligibility Requirements
A topical research project of high scientific quality and originality having a strong application potential. Type and Extent of Funding by IUSSTF
Funding is generally granted for two years. Proposal Evaluation Proposals will be considered on basis of peer - reviews conducted both in India and United States towards Award.
This section covers Industry related funding Schemes from Ministries/Departments of Government of India and other organizations. This would be a monthly feature.
Technology Development Board (TDB)
The Technology Development Board is the first organization of its kind within the Government framework with the sole objective of translating the fruits of indigenous research into commercial products or services.
The objective of TDB is to assist the industrial concerns and other agencies, which attempt development and commercial application of indigenous technology or adapt imported technology to wider domestic applications. Loan Assistance:TDB provides loan assistance to industrial concerns. The industrial concern may be an on-going one or a new one. The loan carries a simple interest of five percent per annum. TDB does not levy processing, administrative or commitment charges. The quantum of loan will be, normally, limited up to 50 per cent of the approved project cost. The duration of the project should not generally exceed three years. The loan is payable in installments that are linked to risk-associated milestones in accordance with the terms and conditions of the loan agreement. The refund of the loan and payment of interest commence one year after the project is completed and the full loan amount is recoverable in five years thereafter. In some cases, TDB may have nominee director(s) on the Board of Directors of the assisted industrial concern. Equity Subscription: TDB may also subscribe by way of equity capital in an industrial concern, on its commencement, start-up and/or growth stages. The equity subscription is decided by the full Board of TDB. It is up to 25 per cent of the approved project cost provided such investment does not exceed the capital paid-up by the promoters. The pre-subscription conditions include that the promoters should have subscribed and fully paid up their portion of the share capital. TDB has a right to have nominee director(s) on the Board of Directors of the company. TDB, in its discretion, may divest its shareholdings in the company after three years of completion of the project or after five years from the date of subscription. The first option to buy back the shares rests with the promoters. Grants by TDB: TDB may also provide financial assistance by way of grants and/or loans to industrial concerns and R&D institutions engaged in developing indigenous technology. TDB is not to be considered a substitute for funding by the Government or other appropriate institutions. The sanction of grants is decided by the full Board of TDB and is sanctioned in exceptional cases. Royalty may be levied in case of grant assistance. For more information please CLICK The Department of Science and Technology (DST)
Drugs & Pharmaceutical Research
Recognizing the profound influence of R&D on the prospects and opportunities for the growth of the Indian Drug Industry, Department of Science and Technology (DST), Government of India mounted the programme on drug development during 1994-95 for promoting collaborative R&D in drugs and pharmaceuticals sector.Special Features Collaborataive R&D Projects
|
